Here's some interesting news, hot off the presses....
Save yourself some time and go to the 3 minute mark. Or watch it all and get a laugh out of the editing (or lack thereof).
I am one of the 19 views.
Cynata are inferring that Mesoblast will fail with the FDA and GVHD.
This is another direct swipe by CYP at MSB. https://www.cynata.com/news
Someone is going to be very wrong.
Note: Rasko and Cynata have never commenced a trial with the FDA. Ever.
This clip requires a response from Mesoblast management.
Cell Therapy News/Articles, page-16225
-
- There are more pages in this discussion • 1,623 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |